252 related articles for article (PubMed ID: 29666781)
1. Role of Muramyl Dipeptide in Lipopolysaccharide-Mediated Biological Activity and Osteoclast Activity.
Kitaura H; Ishida M; Kimura K; Sugisawa H; Kishikawa A; Shima K; Ogawa S; Qi J; Shen WR
Anal Cell Pathol (Amst); 2018; 2018():8047610. PubMed ID: 29666781
[TBL] [Abstract][Full Text] [Related]
2. Muramyl dipeptide enhances lipopolysaccharide-induced osteoclast formation and bone resorption through increased RANKL expression in stromal cells.
Ishida M; Kitaura H; Kimura K; Sugisawa H; Aonuma T; Takada H; Takano-Yamamoto T
J Immunol Res; 2015; 2015():132765. PubMed ID: 26000311
[TBL] [Abstract][Full Text] [Related]
3. Muramyl dipeptide enhances osteoclast formation induced by lipopolysaccharide, IL-1 alpha, and TNF-alpha through nucleotide-binding oligomerization domain 2-mediated signaling in osteoblasts.
Yang S; Takahashi N; Yamashita T; Sato N; Takahashi M; Mogi M; Uematsu T; Kobayashi Y; Nakamichi Y; Takeda K; Akira S; Takada H; Udagawa N; Furusawa K
J Immunol; 2005 Aug; 175(3):1956-64. PubMed ID: 16034140
[TBL] [Abstract][Full Text] [Related]
4. [Bone destruction caused by osteoclasts].
Yamashita T; Takahashi N; Yang S; Sato N; Udagawa N
Clin Calcium; 2006 Feb; 16(2):234-40. PubMed ID: 16465024
[TBL] [Abstract][Full Text] [Related]
5. Effects of two bacterial products, muramyl dipeptide and endotoxin, on bone resorption in organ culture.
Raisz LG; Alander C; Eilon G; Whitehead SP; Nuki K
Calcif Tissue Int; 1982 Jul; 34(4):365-9. PubMed ID: 6291730
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of endotoxin activity by muramyldipeptide.
Takada H; Yokoyama S; Yang S
J Endotoxin Res; 2002; 8(5):337-42. PubMed ID: 12537692
[TBL] [Abstract][Full Text] [Related]
7. Stereo-isomer specific induction of renal cell apoptosis by synthetic muramyl dipeptide (N-acetylmuramyl-L-alanyl-D-isoglutamine).
Langford MP; Chen D; Welbourne TC; Redens TB; Ganley JP
Mol Cell Biochem; 2002 Jul; 236(1-2):63-73. PubMed ID: 12190122
[TBL] [Abstract][Full Text] [Related]
8. Modulation of lipopolysaccharide-induced cytokine gene expression in mouse bone marrow-derived macrophages by muramyl dipeptide.
Le Contel C; Temime N; Charron DJ; Parant MA
J Immunol; 1993 May; 150(10):4541-9. PubMed ID: 8482846
[TBL] [Abstract][Full Text] [Related]
9. Differential feeding responses to bacterial lipopolysaccharide and muramyl dipeptide.
Langhans W; Balkowski G; Savoldelli D
Am J Physiol; 1991 Sep; 261(3 Pt 2):R659-64. PubMed ID: 1887952
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo production of interleukin-6 induced by muramyl peptides and lipopolysaccharide in normal dogs.
Shi F; Kurzman ID; MacEwen EG
Cancer Biother; 1995; 10(4):317-25. PubMed ID: 8590897
[TBL] [Abstract][Full Text] [Related]
11. Muramyl Dipeptide, a Shared Structural Motif of Peptidoglycans, Is a Novel Inducer of Bone Formation through Induction of Runx2.
Park OJ; Kim J; Yang J; Yun CH; Han SH
J Bone Miner Res; 2017 Jul; 32(7):1455-1468. PubMed ID: 28337794
[TBL] [Abstract][Full Text] [Related]
12. MDP-Induced selective tolerance to TLR4 ligands: impairment in NOD2 mutant Crohn's disease patients.
Cantó E; Moga E; Ricart E; Garcia-Bosch O; Garcia-Planella E; Juarez C; Vidal S
Inflamm Bowel Dis; 2009 Nov; 15(11):1686-96. PubMed ID: 19572373
[TBL] [Abstract][Full Text] [Related]
13. Lack of cross tolerance between LPS and muramyl dipeptide in induction of circulating TNF-alpha and IL-6 in guinea pigs.
Roth J; Aslan T; Störr B; Zeisberger E
Am J Physiol; 1997 Oct; 273(4):R1529-33. PubMed ID: 9362320
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effect of muramyldipeptide with lipopolysaccharide or lipoteichoic acid to induce inflammatory cytokines in human monocytic cells in culture.
Yang S; Tamai R; Akashi S; Takeuchi O; Akira S; Sugawara S; Takada H
Infect Immun; 2001 Apr; 69(4):2045-53. PubMed ID: 11254557
[TBL] [Abstract][Full Text] [Related]
15. Sex differences in the effects of muramyl dipeptide and lipopolysaccharide on locomotor activity and the development of behavioral tolerance in rats.
Engeland CG; Kavaliers M; Ossenkopp KP
Pharmacol Biochem Behav; 2003 Jan; 74(2):433-47. PubMed ID: 12479965
[TBL] [Abstract][Full Text] [Related]
16. Lipoteichoic acid and muramyl dipeptide synergistically induce maturation of human dendritic cells and concurrent expression of proinflammatory cytokines.
Kim HJ; Yang JS; Woo SS; Kim SK; Yun CH; Kim KK; Han SH
J Leukoc Biol; 2007 Apr; 81(4):983-9. PubMed ID: 17210616
[TBL] [Abstract][Full Text] [Related]
17. Muramyl dipeptide alleviates estrogen deficiency-induced osteoporosis through canonical Wnt signaling.
Park OJ; Kwon Y; Kim J; Park C; Yun CH; Han SH
J Pathol; 2023 Jun; 260(2):137-147. PubMed ID: 36811349
[TBL] [Abstract][Full Text] [Related]
18. The origin of the synergistic effect of muramyl dipeptide with endotoxin and peptidoglycan.
Wolfert MA; Murray TF; Boons GJ; Moore JN
J Biol Chem; 2002 Oct; 277(42):39179-86. PubMed ID: 12151399
[TBL] [Abstract][Full Text] [Related]
19. MDP(Lysyl)GDP, a nontoxic muramyl dipeptide derivative, inhibits cytokine production by activated macrophages and protects mice from phorbol ester- and oxazolone-induced inflammation.
Zunic M; Bahr GM; Mudde GC; Meingassner JG; Lam C
J Invest Dermatol; 1998 Jul; 111(1):77-82. PubMed ID: 9665390
[TBL] [Abstract][Full Text] [Related]
20. The effect of lipopolysaccharide from bacteroides gingivalis and muramyl dipeptide on osteoblast collagenase release.
Sismey-Durrant HJ; Atkinson SJ; Hopps RM; Heath JK
Calcif Tissue Int; 1989 May; 44(5):361-3. PubMed ID: 2540890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
